Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jul;157(1):123-34.
doi: 10.1016/S0002-9440(10)64524-5.

Endothelin receptor subtype distribution predisposes coronary arteries to damage

Affiliations

Endothelin receptor subtype distribution predisposes coronary arteries to damage

C S Louden et al. Am J Pathol. 2000 Jul.

Abstract

Several vasoactive drugs that lower blood pressure and increase heart rate induce regional cardiotoxicity in the dog, most frequently of right coronary arteries and right atrium. The basis for this selective damage is thought to result from local changes in vascular tone and blood flow. Administration of an endothelin receptor antagonist (ETRA, SB 209670) to dogs induced damage most frequent and severe in the right coronary artery and right atrium. Because site predisposition may correlate with distribution of vasoactive receptors, the objectives of this study were to map endothelin (ET) receptor distribution and density within regions of dog heart using both gene (mRNA) and protein expression endpoints for dog ET(A) and ET(B) receptors, and, additionally, correlate ET receptor subtype density with regional cardiac blood flow. A 10- to 15-mmHg reduction in mean arterial pressure with a concomitant increase in heart rate (10-20%), a six- and twofold increase in regional blood flow to the right and left atrium, respectively, and acute hemorrhage, medial necrosis, and inflammation were observed in the right coronary arteries and arteries of the right atrium after ETRA infusion for 5 days. Radioligand protein binding to quantify both ET receptors in normal dog heart indicated a twofold greater density of ET receptors in atrial regions versus ventricular regions. Importantly, ET receptor density in coronary arteries was markedly (about five- to sixfold) increased above that in atrial or ventricular tissues. ET receptor subtype characterization indicated ET(B) receptors were three times more prevalent in right coronary arteries compared to left coronary arteries and in situ hybridization confirmed localization of ET(B) in vascular smooth muscle. ET(A) receptor density was comparable in right and left coronary arteries. Quantitative real-time polymerase chain reaction for ET(A) and ET(B) receptor mRNA transcripts supported the site prevalence for message distribution. Consequently, the composite of protein and message expression profiles for ET(A) and ET(B) receptors indicated a disproportionate distribution of ET(B) receptors within right coronary artery of dog and this, along with functional measures of blood flow after ETRA infusion indicated a predisposition for exaggerated pharmacological responses and subsequent damage to right coronary arteries by ET and/or ETRAs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Partial nucleotide and amino acid sequences for the dog ETA receptor is shown aligned with homologous region of the human ETA receptor, the non-identical region at the amino acid level are shaded.
Figure 2.
Figure 2.
Mean arterial pressure (MAP; A) and heart rate (HR; B) from control and ETRA infused dogs. *P < 0.05 (statistically significant increase).
Figure 3.
Figure 3.
Regional blood flow from vehicle- and ETRA-infused dogs. Note marked increase in right atrial blood flow after ETRA infusion for 5 days. *P < 0.05 (statistically significant increase). No change was observed in vehicle-infused dogs (inset).
Figure 4.
Figure 4.
Heart from ETRA-infused dog. Note areas of hemorrhage in right atria (A) and right atrial appendage (B). Periarterial inflammation and fibrinoid necrosis of right extramural coronary arteries with inflammation extending into pericardial adipose tissue of the coronary groove (C and D). Multifocal areas of hemorrhage in tunica media of right coronary artery (E and F). H&E stain; original magnifications, ×24 (C), ×120 (D and E), ×240 (F).
Figure 5.
Figure 5.
ETA and ETB receptor density in different regions of the normal dog heart. RCA, right coronary artery; LCA, left coronary artery; RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle.
Figure 6.
Figure 6.
Quantitative analysis of ETA (A) and ETB (B) receptors mRNA by RT-PCR (Taqman) in normal dog heart and coronary arteries (n ≥ 3). The normal dog femoral artery (FA) was use as a reference base and values for all sites are expressed relative to ETA or ETB receptor mRNA abundance in FA.
Figure 7.
Figure 7.
Localization of ETB receptor mRNA expression in extramural coronary arteries of the dog. ETB anti-sense hybridization signal was localized predominantly to the vascular intima and media of the RCA (A). Hybridization signal was weak or absent in the LCA (C) as compared to the RCA (A), suggesting a lower density of ETB receptors in the LCA. Using ETB sense probes, hybridization signal was not observed in either LCA (B) or RCA (not shown). Dark field illumination; original magnifications, ×130.

Similar articles

Cited by

References

    1. Dogterom P, Zbinden G, Reznik GK: Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview. CRC Crit Rev Toxicol 1992, 22:203-241 - PubMed
    1. Gans JH, Korson R, Cates MR, Ackerly CC: Effects of short-term and long term theobromine administration to male dogs. Toxicol Appl Pharmacol 1980, 53:481-496 - PubMed
    1. Harlem JH, Joseph EC, Eden RJ, Walker TF, Major IR, Lamb MS: Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dog. Arch Toxicol 1986, 59:51-55 - PubMed
    1. Herman EH, Balazs T, Young R, Earl FL, Krop S, Ferrans VJ: Acute cardiomyopathy induced by vasodilating antihypertensive agent minoxidil. Toxicol Appl Pharmacol 1979, 47:493-503 - PubMed
    1. Mesfin GM, Shawaryn GG, Higgins MJ: Cardiovascular alterations in dogs treated with hydralazine. Toxicol Pathol 1987, 15:409-416 - PubMed

MeSH terms

Substances

LinkOut - more resources